chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I noticed the next morning after my booster that I had chest pain like a pulled muscle but I had heart palpitations as well. The palpitations discontinued pretty quickly but I still had chest pain. The following day I began to have joint pain and inflammation in my right hand. I also began to have it in my left had as well. They were pretty inflamed. I wasn't able to get into see the doctor but plan to go today, possibly. I have notice my fingers have improved, not as much pain and I cannot see swelling anymore. They feel stiff though and not gone completely.
Got COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID-19). At the time of the report, COVID-19 (Got COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. No Treatment information was reported.
Client showed up to office appt. with reddened, slightly swollen arm where DTAP shot had been given days earlier. Mother was unaware until nurse noticed it.
her mouth and lips begin to tingle and her tongue feels like she has eaten something hot an burned it; her mouth and lips begin to tingle and her tongue feels like she has eaten something hot an burned it; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received first dose of BNT162B2 (Solution for injection, Lot# EL9264), via intramuscularly on 29Jan2021 11:40 at single dose in the upper right arm for covid-19 immunization. Medical history included ongoing blood pressure abnormal, ongoing Vitamin supplementation, Complete Hysterectomy and ongoing blood thinning. A long time ago she had a reaction to flu shot and has not had any reactions to ones she has received 2-3 years since. Manufacturer, dose, lot and expiration are unknown. She just got the flu from it. She had Polio when she was younger, and she was concerned. Concomitant medication included estrogens conjugated (PREMARIN), on an unknown date in 1983 at 0.3 mg, daily for Complete Hysterectomy, and reported as, taking it for 30 years at smallest dose. If she does not take it, she has migraine headaches, lisinopril at 20-25mg, once daily for Blood pressure and reported as taken it for quite some time, vitamin d3, vitamin c [ASCORBIC ACID] and zinc at 1 DF, daily for Vitamin supplementation and reported as started 6 months ago to build immune system, when everything started coming out about COVID, acetylsalicylic acid (COATED ASPIRIN) 81 mg, every other day for Blood thinning and reported as takes it because at one time they thought she had a blockage, but she did not. The patient previously took Penicillin, Biaxin, Crestor, Sulfa drugs, adhesive tape and experienced drug hypersensitivity. No manufacturer for Penicillin and sulfa drugs. She does not have a lot or expiration for any of them. Received call from consumer regarding the Pfizer COVID vaccine. On 29Jan2021 12:15, Friday and her mouth and lips begin to tingle. "It was like her tongue had eaten something hot and felt like how you burn your tongue." Saturday, it was not any different. She took Benadryl and it was still the same way. She wondered if she had a reaction to the vaccine. She did talk to family doctor and he told her to take Benadryl, Tylenol and drink fluid. He still recommended she take second vaccine. Benadryl dose was 25 mg, Lot P115109, Expiration May2022. It was sealed and intact. She would be willing to send a sample. Therapeutic measures were taken as a result of her mouth and lips begin to tingle and her tongue feels like she has eaten something hot an burned it. The outcome of the events was not recovered.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult male patient of unspecified age. This refers to 547of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (TIV) Thiomersal (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in a cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination. The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
PATIENT RECIEVED VARIVAX ON 01-29-99. NOW HAS CHICKEN POX.
Pain and swelling with increased sensation of heat in arm where injection was administered. Also some rash, itching, shoulder pain.
I was at a choral practice where I believe to have contracted COVID-19. I started with a symptom of cough and sore throat which led to congestion, fatigue and night sweats. I did not run a fever though. I took PCR COVID-19 test that came back positive. I contacted the advise nurse and the doctor prescribed me with Paxlovid, which I took for five days.
This spontaneous report was received from a Registered nurse referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions and drug reactions/allergies were not provided. Between 11-JAN-2018 and 08-MAR-2018, the patients were vaccinated with improperly stored doses of GARDASIL 9, lot # N013276, expiration date on 21-JAN-2020; lot #N017686, expiration date on 02-FEB-2020; M-M-R II, lot #M044350, expiration date on 04-NOV-2018; lot #N010495, expiration date on 31-MAR-2019; which were concomitantly reconstituted with Merck sterile diluent; and LIQUID PEDVAXHIB, lot #N012921, expiration date on 28-FEB-2020. All vaccines were administered for prophylaxis (strengths, doses and routes of administration were not reported). Between 11-JAN-2018 and 16-MAR-2018, there were temperature excursions between 30.40 degrees F and 48.00 degrees F for 0.25-1 hour. No adverse effects were reported in any of the patients. The call was because of a data logger. This is a non-valid case due to lack of patient identifier. Follow-up information was received on 05-SEP-2018. It was confirmed that the patient was 3 month old infant. On 29-MAR-2018, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB, lot #N012921 (expiry date: 28-FEB-2020) for prophylaxis (strength, dose and route of administration were not reported). This case was previously considered non-valid, but per current process it was determined to be valid as patient identifiers were provided. This is one of several reports received from the same reporter. Follow-up call was placed to the Registered nurse on 05-SEP-2018 regarding patient(s) identifiers and dates of vaccination. The correspondence process was reviewed. Sender's Comments: US-009507513-1809USA002916; US-009507513-1809USA002917; US-009507513-1809USA002918; US-009507513-1809USA002919; US-009507513-1809USA002920; US-009507513-1809USA002921; US-009507513-1809USA002922; US-009507513-1809USA002923.
December 19th = neck pain and then shoulder pain  same day as vaccination. It was in the same arm as the polio shot.  December 20th = Woke up next day with fever of 103 and armpit pain. Same side. It hurt to lift her arms. She was exhausted all day. Not herself.  Cried hysterically from stomach pain and her shoulder and armpit hurting all day. December 21st= couldnt communicate or speak. just sat there. have a video of it.  fever still on board. December 22nd= fever finally broke with tylenol on board. started to talk briefly. lump still present in her arm pit. December 23rd= able to communicate a bit more and finally ate. by christmas she was back to herself. i am terrified.
I began having chest pains, trouble breathing, dizziness, finally at 10:45 AM I passed out and fell to the floor at work.  I was then sent to the emergency room at the hospital in an ambulance.  Where they diagnosed me with dehydration and an elevated white blood cell count as if my body were under attack by a serious virus.  After giving me an EKG and blood tests to rule out a heart attack, they then gave me a CAT scan to rule out a pulmanary embolism.  Theses tests came back negative.  They gave me baby aspirin and 2 large potassium pills because I was very low.
Site: Pain at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.), Additional Details: District leadder called and informed of this complaint. Patient is experiencing arm pain since vaccination
Extra varicella dose given in error. Nurse looked at immunization record incorrectly and gave 3rd dose varicella instead of 2nd dose MMR. Parent was notified immediately on site and correct vaccine give. Parent advised extra dose is not harmful and should not cause any issues besides routine vaccine side effects. Advised to contact office if any questions or concerns.
pt reports 2 hrs p/vax started perspiring 3-4 hrs p/inject had SOB & felt nauseated; next day pt noticed a reddened site 2 inches wide (that reportedly looked like a bruise); 23OCT93 pt was advised to go to ER; MD stated was blood clot;
SEVERE joint pain within minutes.  My wrist swelled up to the point where my watch band was leaving an indent on my skin. Sever nerve pain all over my body within minutes. Left hip muscles hurting badly within minutes. General muscle aches all over within minutes.   Lots of fatigue.
headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hot, nauseous, dizzy, then followed by severe chills for more than 1 hour and a temperature around 100.  Took 2 Advil and went to bed.  Heavy sweating all night.  Aching in morning.  Tired later in the day.  OK by 6:00 PM.
Patient shared that she had severe headache, body ache, diarrhea.; Patient shared that she had severe headache, body ache, diarrhea.; Patient shared that she had severe headache, body ache, diarrhea.; This is a spontaneous report from a contactable consumer. An adult female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown whether the patient was pregnant. Medical history and concomitant medication was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. The patient shared with the reporter that on an unknown date she had severe headache, body ache, diarrhea. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events severe headache, body ache, diarrhea were resolved on an unknown date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of DRUG INTERACTION (RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced DRUG INTERACTION (RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE). At the time of the report, DRUG INTERACTION (RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE) outcome was unknown.            No concomitant medication was reported. In 2021, the patient experienced RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE. MODERNA COVID-19 VACCINE (COVID-19 VACCINE MRNA(MRNA 1273)) was also considered suspect.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medication was reported.   Causality for HUMIRA(ADALIMUMAB): The reporter's causality for the event(s) of RHEUMATOID ARTHRITIS NOT HELP BY HUMIRA/LACK OF EFFECT AFTER COVID VACCINE was not provided.    This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Redness, warmth, tenderness around inject site (L thigh) 18 hrs post vax. No fever. Resolved in 3 days.
About 25 - 35 minutes after receiving the vaccine at a vaccine Clinic, I felt a metal taste in my mouth and my lips and my lower cheek area started tingling.  I got worried and went to an urgent care clinic where they thought that it was a minor reaction.   I went home and had breakfast and felt much better within 2 hours.  Have felt fine since.  Had a sore arm for one day, no redness, or swelling.
No additional adverse event; inadvertently adrninistered a dose of PNEUMOVAX 23, that was expired; This spontaneous report as received from a physician refers to a 2-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 18-JUN-2020, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # R031961, expiration date 09-JUN-2020 (dose and route of administration) for prophylaxis. There was no adverse event reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: R031961; expirationdate: 09-JUN-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Patient received first dose of Pfizer COVID vaccine  12/31/2021.    On 1/5/2021 developed cough, sore throat, and body aches.  Tested positive for COVID.
Peripheral neuropathy; pain was terrible in both feet; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01May2021 (Lot number: ER8730) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing); "migraines" (unspecified if ongoing), notes: migraines; "Hypothyroid" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; LEXAPRO; PROBIOTICS; KLONOPIN; VISTARIL [HYDROXYZINE EMBONATE]. Past drug history included: Macrobid, reaction(s): "Drug Allergy", notes: Macrobid; Erythromycin, reaction(s): "Drug Allergy", notes: Erythromycin; Keflex, reaction(s): "Drug Allergy", notes: Keflex; Bactrim, reaction(s): "Drug Allergy", notes: Bactrim. Vaccination history included: Pfizer (DOSE 1, SINGLE, Batch/Lot No: EW0170, Location of injection: Arm Left), administration date: 01Apr2021, when the patient was 50 years old, for Covid-19 immunization, reaction(s): "right big toe pain. Then it moved to all". No other vaccine was given in four weeks. The following information was reported: NEUROPATHY PERIPHERAL (disability, medically significant) with onset May2021, outcome "not recovered", described as "Peripheral neuropathy"; PAIN IN EXTREMITY (disability) with onset May2021, outcome "not recovered", described as "pain was terrible in both feet". Right after the first dose, the patient started having right big toe pain. Then it moved to all toes, after second injection pain was terrible in both feet. She was tested for all possible causes and there was none. It was directly after Covid shots. The events "peripheral neuropathy" and "pain was terrible in both feet" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: electromyogram: peripheral neuropathy; sars-cov-2 test: negative. Therapeutic measures were taken as a result of neuropathy peripheral, pain in extremity and it included Toe injection and medications.; Sender's Comments: Based on the information currently available, a possible contribution of the suspect drug administration BNT162B2 to the reported events neuropathy peripheral, pain in extremity cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Muscle pain; Extreme tiredness; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Aug2021 12:00 (Lot number: FC3183) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "PCOS" (unspecified if ongoing); "known allergies: Latex" (unspecified if ongoing), notes: known allergies: Latex; "known allergies: Sulfa meds" (unspecified if ongoing), notes: known allergies: Sulfa meds. Concomitant medication(s) included: PROGESTERONE; SPIRONOLACTONE; ALLEGRA. The following information was reported: MYALGIA (non-serious) with onset 24Aug2021 22:00, outcome "recovering", described as "Muscle pain"; FATIGUE (non-serious) with onset 24Aug2021 22:00, outcome "recovering", described as "Extreme tiredness"; HEADACHE (non-serious) with onset 24Aug2021 22:00, outcome "recovering", described as "Headache". Therapeutic measures were not taken as a result of myalgia, fatigue, headache.  Additional Information: The patient did not receive any vaccine in four weeks. The patient did not have covid prior to vaccination. The patient was not tested for covid post-vaccination.Device time stamp: 25Aug2021.  No follow-up attempts are possible. No further information is expected.
All mild symptoms in list except stomach issues. Fever, joint and muscle pains, headache, exhaustion, chills
The patient received  the Pfizer vaccine at age 11.  The mother filled out the consent form online with an incorrect birthdate. The administering pharmacist confirmed the birthdate before immunization. Another agency contacted the pharmacy after immunization advising of the actual patient date of birth. The pharmacist subsequently called patient's father who confirmed the birthdate given by the agency is correct.
Fever of 103, chills, muscle cramps, migraine, dizzy, loss of appetite. High fever for 12 hours, low fever the next day, fever gone by third day.
Pt began experiencing symptoms on 12/10/95. She was clumsy were developed into more severe walking difficulty. She had drop in left foot and numbness in left leg to thigh. This developed into urinary urgency and numbness in arm and face. By 1/2/97, pt had tremors, facial paralysis, leg spasms, left hand immobile, extreme weakness, and shortness of breath. She also developed vision loss and intense seizures. She experienced diplopia and blurred vision on the right side.  Treated with plasmapheresis. Finally dx with dystonia, CIDP, and autoimmune disorder. Follow up states that a primary diagnosis of inflammatory demyelinating polyneuropathy was made on 10/04/96.60 day follow-up dated 7/21/00 provided a change in age.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021 at 1:54 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 1:54 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 52.93  Concomitant products were not provided.  On 28-Mar-2021, Excursion time was 10AM temperature was 35 total doses given for the day was 150, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 15 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Approximately 4 years post vax, this pt was dxed with chickenpox by physician. It was reportedly mild with 20-25 lesions and not all lesions were vesiculated. It was noted that the pt had been exposed to her cousin who had varicella 2 weeks prior to the pt's rash.